A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for biopharma. From digital transformation to an AI revolution to more ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

At Fast Company and Johns Hopkins University's World Changing Ideas Summit in November, leaders shared what's top of mind for ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the ...

Chemical biology increasingly benefits from the close integration of experimental structural techniques and computational ...

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

Eli Lilly and Co. to open a research lab that will use artificial intelligence to speed up drug discovery. The companies ...